Pharmacyclics Inc (PCYC) Financial Statements (2024 and earlier)

Company Profile

Business Address PHARMACYCLICS INC
SUNNYVALE, CA 94085-4521
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments856,987736,479677,983690,056635,628560,100
Cash and cash equivalents845,035724,533666,279678,625623,956548,433
Short-term investments11,95211,94611,70411,43111,67211,667
Receivables64,29753,32545,33527,01311,04453,781
Inventory, net of allowances, customer advances and progress billings34,44641,40638,30128,71412,603
Inventory34,44641,40638,30128,71412,603 
Advances on inventory purchases 12,883    
Other undisclosed current assets59,82918,78821,91327,23781,52610,529
Total current assets:1,015,559862,881783,532773,020740,801624,410
Noncurrent Assets
Property, plant and equipment32,47631,45630,49029,80025,47120,856
Intangible assets, net (including goodwill)8,7308,9139,096 
Intangible assets, net (excluding goodwill)8,7308,9139,096   
Other noncurrent assets3,3423,3142,9702,9402,4793,033
Total noncurrent assets:44,54843,68342,55632,74027,95023,889
TOTAL ASSETS:1,060,107906,564826,088805,760768,751648,299
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities115,30992,00787,68464,42180,05059,775
Taxes payable703323301,448 
Employee-related liabilities19,64517,18616,171   
Accounts payable7,3152,0426,3131,2304,0264,896
Accrued liabilities88,27972,74665,17763,16174,57654,879
Deferred revenue and credits18,77315,18515,16512,8627,5817,411
Other undisclosed current liabilities60,15437,11727,18817,890  
Total current liabilities:194,236144,309130,03795,17387,63167,186
Noncurrent Liabilities
Liabilities, other than long-term debt36,70641,04543,38046,21653,49752,761
Deferred revenue and credits34,88539,32941,71644,64852,02552,761
Other liabilities1,8211,7161,6641,5681,472 
Total noncurrent liabilities:36,70641,04543,38046,21653,49752,761
Total liabilities:230,942185,354173,417141,389141,128119,947
Equity
Equity, attributable to parent829,165721,210652,671664,371627,623528,352
Common stock888877
Additional paid in capital959,637915,172888,057862,693844,220809,191
Accumulated other comprehensive loss(8)(14)(16)(9)(8)(13)
Accumulated deficit(130,472)(193,956)(235,378)(198,321)(216,596)(280,833)
Total equity:829,165721,210652,671664,371627,623528,352
TOTAL LIABILITIES AND EQUITY:1,060,107906,564826,088805,760768,751648,299

Income Statement (P&L) ($ in thousands)

3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
Revenues290,192207,140113,020119,377123,55179,088
Revenue, net185,136141,608109,49556,179  
Cost of revenue(98,208)(76,615)(59,400)(30,234)  
Cost of goods and services sold(13,373)(11,622)(9,305)(6,110)  
Gross profit:191,984130,52553,62089,143123,55179,088
Operating expenses(98,993)(82,156)(90,824)(70,918)(67,431)(25,662)
Other undisclosed operating income     29,311 
Operating income (loss):92,99148,369(37,204)18,22585,43153,426
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
  (116)(42)  
Other undisclosed income from continuing operations before equity method investments, income taxes61182808148
Income (loss) from continuing operations before income taxes:93,05248,370(37,238)18,26385,43953,574
Income tax expense (benefit)(29,568)(6,948)18112(21,202)(11,241)
Income (loss) from continuing operations:63,48441,422(37,057)18,27564,23742,333
Income (loss) before gain (loss) on sale of properties:63,48441,422(37,057)18,27564,23742,333
Net income (loss) available to common stockholders, diluted:63,48441,422(37,057)18,27564,23742,333

Comprehensive Income ($ in thousands)

3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
Net income (loss):63,48441,422(37,057)18,27564,23742,333
Comprehensive income (loss):63,48441,422(37,057)18,27564,23742,333
Other undisclosed comprehensive income (loss), net of tax, attributable to parent62(7)(1)52
Comprehensive income (loss), net of tax, attributable to parent:63,49041,424(37,064)18,27464,24242,335

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: